Sex and lifestyle drugs: The pursuit of the fountain of youth

Clinical Pharmacology and Therapeutics

Volumn 89, Issue 1, 2011, Pages 3-9

  Kim, M J ^a   Uhl, K ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; COSMETIC; ESTROGEN; FLIBANSERIN; NITRIC OXIDE; PHOSPHODIESTERASE V INHIBITOR; SILDENAFIL; SUNSCREEN; TESTOSTERONE; VITAMIN;

AGING; ANDROPAUSE; ANGINA PECTORIS; CARDIOVASCULAR RISK; CLINICAL TRIAL; CUTANEOUS PARAMETERS; EMPLOYMENT STATUS; ENVIRONMENTAL FACTOR; ERECTILE DYSFUNCTION; FEMALE SEXUAL DYSFUNCTION; HUMAN; HYPOACTIVE SEXUAL DESIRE DISORDER; LIFE EXPECTANCY; LIFESPAN; LIFESTYLE; NONHUMAN; NYMPHOMANIA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN TARGETING; QUALITY OF LIFE; REVIEW; RISK FACTOR; SEXUAL BEHAVIOR; SEXUAL FUNCTION; SIGNAL TRANSDUCTION; SUN EXPOSURE; SUNBURN; ULTRAVIOLET B RADIATION; VAGINA ATROPHY; VASOCONSTRICTION;

AGING; BEAUTY; FEMALE; HEALTH BEHAVIOR; HUMANS; LIFE STYLE; MALE; PERSONAL SATISFACTION; QUALITY OF LIFE; SEXUAL BEHAVIOR; SEXUAL DYSFUNCTION, PHYSIOLOGICAL;

EID: 78650453304     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2010.263     Document Type: Review

References (27)

1. Burke, L.B., Kennedy, D.L., Miskala, P.H., Papadopoulos, E.J. & Trentacosti, A.M. The use of patient-reported outcome measures in the evaluation of medical products for regulatory approval. Clin. Pharmacol. Ther. 84, 281-283 (2008).
2. Pharmaceutical Research and Manufacturers of America. 2008 Report: Medicines in Development for Older Americans. More than 2,000 medicines in clinical testing to combat diseases of aging. http://www.Phrma.Org/files/ attachments/Older%20 Americans%20New%20Meds%202008.Pdf (2008).
3. Spectra Intelligence. Market Report: The World Market for Sexual Disorders, 2005-2012: Traversing New Frontiers in Sexual Chemistry .http://www. mindbranch.Com/listing/product/R3417-6.html (January 2006).
4. Lindau, S.T., Schumm, L.P., Laumann, E.O., Levinson, W., O'Muircheartaigh, C.A. & Waite, L.J. A study of sexuality and health among older adults in the United States. N. Engl. J. Med. 357, 762-774 (2007).
5. Laumann, E.O., Glasser, D.B., Neves, R.C. & Moreira, E.D. Jr. for the GSSAB Investigators' Group. A population-based survey of sexual activity, Sexual problems and associated help-seeking behavior patterns in mature adults in the United States of America. Int. J. Impot. Res. 21, 171-178 (2009).
6. Pharmaceutical Research and Manufacturers of America. Facts about diseases/conditions affecting women. PhRMA Backgrounder .http://www.Phrma. org/files/attachments/2009-Women-Disease%20 Backgrounder.pdf (October 2009).
7. Tamler, R. Diabetes, Obesity, And erectile dysfunction. Gend. Med. 6, 4-16 (2009).
8. Shames, D., Monroe, S.E., Davis, D. & Soule, L. Regulatory perspective on clinical trials and end points for female sexual dysfunction, In particular, Hypoactive sexual desire disorder: formulating recommendations in an environment of evolving clinical science. Int. J. Impot. Res. 19, 30-36 (2007).
9. Basson R. Clinical practice. Sexual desire and arousal disorders in women. N. Engl. J. Med. 354, 1497-1506 (2006).
10. Jordan, R., Hallam, T.J., Molinoff, P. & Spana, C. Developing treatments for female sexual dysfunction. Clin. Pharmacol. Ther. 89, 137-141 (2011).
11. Winneker, R.C. & Harris, H.A. Progress and prospects in treating postmenopausal vaginal atrophy. Clin. Pharmacol. Ther. 89, 129-132 (2011).
12. US Food and Drug Administration. Reproductive Health Drugs Advisory Committee. http://www.fda.Gov/AdvisoryCommittees/CommitteesMeetingMaterials/ Drugs/ReproductiveHealthDrugsAdvisoryCommittee/default.htm (12 July 2010).
13. Tran, D.C., Apparaju, S., Yu, C., Lee., L, Kim, H. & Kim, M-J. Clinical pharmacology aspects of sex-related products. Clin. Pharmacol. Ther. 89, 26-28 (2011).
14. Nilsson, S. & Gustafsson, J-Å. Estrogen receptors: therapies targeted to receptor subtypes. Clin. Pharmacol. Ther. 89, 44-55 (2011).
15. Serretti, A. & Chiesa, A. Sexual side effects of pharmacologic treatment of psychiatric diseases. Clin. Pharmacol. Ther. 89, 142-147 (2011).
16. BCC Research. Anti-Aging Products and Services: The Global Market. Report HLC060A. Projections for anti-aging market in 2013 http://www.Bccresearch.Com/ report/HLC060A.html (May 2009).
17. Rijken, F. & Bruijnzeel-Koomen, C.A.F.M. Photoaged skin: the role of neutrophils, Preventive measures, And potential pharmacological targets. Clin. Pharmacol. Ther. 89, 120-124 (2011).
18. Sachs, D.L. & Voorhees, J.J. Age-reversing drugs and devices in dermatology. Clin. Pharmacol. Ther. 89, 34-43 (2011).
19. Berwick, M. The good, The bad, And the ugly of sunscreens. Clin. Pharmacol. Ther. 89, 31-33 (2011).
20. Hart, G. & Wellings, K. Sexual behaviour and its medicalisation: in sickness and in health. BMJ 324, 896-900 (2002).
21. Johnson, E., Sjögren, E. & Åsberg, C. Prescribing for the "Swedish Viagra Man". Clin. Pharmacol. Ther. 89, 15-16 (2011).
22. Bechara, A., Casabé, A., De Bonis, W., Helien, A. & Bertolino, M.V. Recreational use of phosphodiesterase type 5 inhibitors by healthy young men. J. Sex. Med. 7, 3736-3742 (2010).
23. Apodaca, T.R. & Moser, N.C. The use and abuse of prescription medication to facilitate or enhance sexual behavior among adolescents. Clin. Pharmacol. Ther. 89, 22-24 (2011).
24. Polinski, J.M. & Kesselheim, A.S. Where cost, Medical necessity, And morality meet: should US government insurance programs pay for erectile dysfunction drugs? Clin. Pharmacol. Ther. 89, 17-19 (2011).
25. Hornbrook, M.C. & Holup, J. Insurance coverage for erectile dysfunction drugs . Clin. Pharmacol. Ther. 89, 19-21 (2011).
26. Basaria, S. et al. Adverse events associated with testosterone administration. N. Engl. J. Med. 363, 109-122 (2010).
27. Cook, N.L. & Romashkan, S. Why do we need a trial on the effects of testosterone therapy in older men? Clin. Pharmacol. Ther. 89, 29-31 (2011).